Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
09109-cover1-SaltigoFrankfurtcxd.jpg

March 4, 2013 Cover

Volume 91, Issue 9

Biotech firms rely on contract manufacturers for help and guidance on the road to market for new molecules

Cover image:

Credit:

Full Article
Volume 91 | Issue 9

All Issues

Pharmaceuticals

Turning Ideas Into Drugs

Biotech firms rely on contract manufacturers for help and guidance on the road to market for new molecules

  • China Bets Big On Drug Research

    Money and accomplished scientists boost efforts to build world-class pharmaceutical institutes

  • Weighing In On EPA Research

    Science advisers to suggest improvements for work on computational toxicology, cost estimates of regulations

  • A Positive Ending To A Tough Year

    Fourth-quarter chemical earnings increase as the industry learns to boost profit margins even as sales stagnate

ADVERTISEMENT
image name
Synthesis

Composite Catalyst For Chiral Synthesis

Catalytic metal particles embedded in monolayers of chiral molecules yield solid catalysts that facilitate enantioselective reactions

ADVERTISEMENT
ADVERTISEMENT